Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 405 | 674 | 743 | 810 | 853 |
| Gross Profit | 405 | 674 | 743 | 810 | 853 |
| Operating Expenses | 10,355 | 8,804 | 8,938 | 10,906 | 13,695 |
| Operating Income | -9,950 | -8,130 | -8,195 | -10,096 | -12,842 |
| Interest Expense | 0 | 0 | 0 | 0 | -227 |
| Other Income | 122 | 250 | 561 | -77 | 0 |
| Pre-tax Income | -9,828 | -7,880 | -7,634 | -10,173 | -12,615 |
| Net Income Continuous | -9,828 | -7,880 | -7,634 | -10,173 | -12,615 |
| Net Income | $-9,828 | $-7,880 | $-7,634 | $-10,173 | $-12,615 |
| EPS Basic Total Ops | -11.94 | -21.72 | -60.00 | -60.00 | -180.00 |
| EPS Basic Continuous Ops | -11.94 | -21.73 | -35.83 | -74.83 | -136.85 |
| EPS Diluted Total Ops | -11.94 | -21.72 | -60.00 | -60.00 | -180.00 |
| EPS Diluted Continuous Ops | -11.94 | -21.73 | -35.83 | -74.83 | -136.85 |
| EPS Diluted Before Non-Recurring Items | -11.94 | -21.80 | -35.80 | -74.80 | -136.00 |
| EBITDA(a) | $-9,926 | $-8,123 | $-8,180 | $-10,082 | $-12,828 |